益得 (6461)
益得 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$7.21M, up 18.1% from a year earlier. EPS over the last four quarters totals -NT$2.92.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2018-03-28
- Founded
- 2010-10-28
- Paid-in capital
- NT$1.10B
- Common shares issued
- 110,324,527
- Legal name
- 益得生物科技股份有限公司
- Website
- http://www.intechbiopharm.com
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$7.21M | +27.5% | +18.1% |
| 2026-08 | NT$5.65M | +2579.6% | +1103.0% |
Year to date: -51.8% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.59 |
| 2026 Q1 | -0.63 |
| 2025 Q4 | -0.77 |
| 2025 Q3 | -0.93 |
| 2025 Q2 | -0.23 |
| 2025 Q1 | -0.64 |
| 2024 Q4 | -0.76 |
| 2024 Q3 | -0.70 |
Last four quarters: -NT$2.92
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 4,908 | 1.2% |
| 1,000–5,000 shares | 2,663 | 5.2% |
| 5,001–10,000 shares | 586 | 3.8% |
| 10,001–15,000 shares | 226 | 2.5% |
| 15,001–20,000 shares | 113 | 1.8% |
| 20,001–30,000 shares | 125 | 2.7% |
| 30,001–40,000 shares | 64 | 2.0% |
| 40,001–50,000 shares | 45 | 1.8% |
| 50,001–100,000 shares | 93 | 5.8% |
| 100,001–200,000 shares | 54 | 7.2% |
| 200,001–400,000 shares | 21 | 5.2% |
| 400,001–600,000 shares | 12 | 5.1% |
| 600,001–800,000 shares | 3 | 1.8% |
| 800,001–1,000,000 shares | 0 | 0.0% |
| 1,000,001+ shares | 5 | 53.9% |
TDCC data for 2026-10-16: 5 holders own more than 1,000 lots (53.9% of shares), and 4,908 hold less than one lot (1.2%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 10 | 0 | 0 | 10 |
| 2026-10-16 | -3 | 0 | 0 | -3 |
| 2026-10-15 | 7 | 0 | 0 | 7 |
| 2026-10-14 | -12 | 0 | 0 | -12 |
| 2026-10-13 | -5 | 0 | 0 | -5 |
| 2026-10-12 | -1 | 0 | 0 | -1 |
| 2026-10-08 | -17 | 0 | 0 | -17 |
| 2026-10-07 | 7 | 0 | -1 | 6 |
| 2026-10-06 | -51 | 0 | 1 | -50 |
| 2026-10-05 | 44 | 0 | 0 | 44 |
| 2026-10-02 | 74 | 0 | 0 | 74 |
| 2026-10-01 | 14 | 0 | -1 | 13 |
| 2026-09-30 | 12 | 0 | 0 | 12 |
| 2026-09-29 | 1 | 0 | 0 | 1 |
| 2026-09-24 | -4 | 0 | 0 | -4 |
| 2026-09-23 | 0 | 0 | 0 | 0 |
| 2026-09-22 | -20 | 0 | 0 | -20 |
| 2026-09-21 | -6 | 0 | 0 | -6 |
| 2026-09-18 | 3 | 0 | -1 | 2 |
| 2026-09-17 | -25 | 0 | 1 | -24 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 27 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$28.60 (2026-10-19); 52-week range NT$14.10–29.80.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.